These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7198983)

  • 1. Attempted targeting of a monoclonal antibody in a human tumour xenograft system.
    Warenius HM; Galfre G; Bleehen NM; Milstein C
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1009-15. PubMed ID: 7198983
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of IgM monoclonal antibody in mice with human tumour xenografts: lack of tumour localization.
    Pimm MV; Baldwin RW
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):765-8. PubMed ID: 4018119
    [No Abstract]   [Full Text] [Related]  

  • 3. The spatial distribution of parenterally administered monoclonal antibodies against CEA in a human colorectal tumour xenograft.
    Ahlström H; Enblad P; Andersson A; Lörelius LE
    Acta Oncol; 1989; 28(1):81-6. PubMed ID: 2706137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
    Harwood PJ; Pedley RB; Boden J; Rawlins G; Pentycross CR; Rogers GT; Bagshawe KD
    Br J Cancer; 1985 Nov; 52(5):797-9. PubMed ID: 2998427
    [No Abstract]   [Full Text] [Related]  

  • 5. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
    Deckert PM; Jungbluth A; Montalto N; Clark MA; Finn RD; Williams C; Richards EC; Panageas KS; Old LJ; Welt S
    Int J Cancer; 2000 Aug; 87(3):382-90. PubMed ID: 10897044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
    Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
    Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
    [No Abstract]   [Full Text] [Related]  

  • 8. Further biologic characteristics of a human carcinoembryonic antigen-producing colon carcinoma cell line.
    Drewinko B; Yang LY; Barlogie B; Romsdahl M; Meistrich M; Malahy MA; Giovanella B
    J Natl Cancer Inst; 1978 Jul; 61(1):75-83. PubMed ID: 276641
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides.
    Lindholm L; Holmgren J; Svennerholm L; Fredman P; Nilsson O; Persson B; Myrvold H; Lagergård T
    Int Arch Allergy Appl Immunol; 1983; 71(2):178-81. PubMed ID: 6840874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered metabolism of carcinoembryonic antigen in hamsters bearing GW-39 tumours.
    Primus FJ; Hansen HJ; Goldenberg DM
    Nature; 1974 Jun; 249(460):837-8. PubMed ID: 4834788
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
    Kalofonos H; Rowlinson G; Epenetos AA
    Cancer Res; 1990 Jan; 50(1):159-63. PubMed ID: 2403414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo.
    Greiner JW; Guadagni F; Noguchi P; Pestka S; Colcher D; Fisher PB; Schlom J
    Science; 1987 Feb; 235(4791):895-8. PubMed ID: 3580039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
    Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of monoclonal antibody distribution and prolonged tumour localisation in nude mice bearing a human CEA-producing colon carcinoma xenograft.
    Rogers GT; Harwood PJ; Pedley RB; Boden J; Rawlins G; Bagshawe KD
    Tumour Biol; 1986; 6(5):453-63. PubMed ID: 3704478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
    Rowlinson-Busza G; Maraveyas A; Epenetos AA
    Br J Cancer; 1995 Apr; 71(4):660-5. PubMed ID: 7710925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
    Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
    Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.
    Moshakis V; McIlhinney RA; Raghavan D; Neville AM
    Br J Cancer; 1981 Jul; 44(1):91-9. PubMed ID: 6789857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.
    Quayle JB
    Br J Cancer; 1982 Aug; 46(2):220-7. PubMed ID: 7150474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
    Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72.3.
    Keenan AM; Colcher D; Larson SM; Schlom J
    J Nucl Med; 1984 Nov; 25(11):1197-203. PubMed ID: 6333494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.